.• Presented the paper (poster session) “Molecular Markers including S VEGF as predictive factors in response to anthracycline based neo adjuvant chemotherapy in patients with Locally Advanced Breast Cancer” at the IMPAKT breast cancer conference in Belgium in May 2012.
• Poster presentation: “The cost of treatment of AML: An Indian experience” at the ESMO congress, Vienna, September 2012
.• Accepted for publication in abstract book - “Molecular Markers as prognostic factors and response to anthracycline based chemotherapy in patients with Locally Advanced Breast Cancer – Experiences from a developing nation” in ESMO congress, Vienna, September 2012.
• EGFR TKI Erlotinib in Patients with Advanced Squamous Cell Carcinoma of the Lung: A Retrospective Analysis from India Devavrat Arya, September 2015Volume 10, Issue 9, Supplement 2, Pages S761–S790
• Addition of docetaxel or abiraterone to androgen deprivation therapy in metastatic castration-naive prostate cancer in South Asian population: ASCO 2019, co - author
T.• Prevalence of germline BRCA1 and BRCA2 mutations and variants among ovarian, primary peritoneal and fallopian tube cancer patients: A multicentre Indian study : Poster at ESMO 2019, co -author